scispace - formally typeset
S

Susanne Rössner

Researcher at University of Erlangen-Nuremberg

Publications -  15
Citations -  4203

Susanne Rössner is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Dendritic cell & T cell. The author has an hindex of 12, co-authored 15 publications receiving 4041 citations.

Papers
More filters
Journal ArticleDOI

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

TL;DR: This method allows by simple means the generation of high numbers of murine DC with very low B cell or granulocyte contaminations, which will be valuable to study DC biology notably at the molecular level.
Journal ArticleDOI

Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo

TL;DR: These maturation‐resistant immature GMlo DC induced T cell unresponsiveness in vitro and in vivo and may have important implications for future studies in T cell tolerance induction in vivo.
Journal ArticleDOI

Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro

TL;DR: The generation of MSC is described as myeloid DC precursors with potent suppressive activity on allogeneic and OVA‐specific CD4+ and CD8+ T cell responses in vitro preceding their development into immature DC.
Journal ArticleDOI

Differential Functions of IL-4 Receptor Types I and II for Dendritic Cell Maturation and IL-12 Production and Their Dependency on GM-CSF

TL;DR: IL-4 and IL-13 are able to promote DC maturation, as evaluated by up-regulation of MHC class II and costimulatory molecules, when the concentration of GM-CSF is relatively lower than the dose of IL-4 or IL- 13, and under these conditions both cytokines enable DC to respond to maturation stimuli such as bacterial products or proinflammatory cytokines.
Journal ArticleDOI

Dendritic Cells Matured With TNF can be Further Activated In Vitro and After Subcutaneous Injection In Vivo Which Converts Their Tolerogenicity Into Immunogenicity

TL;DR: It is shown that TNF/DC are not terminally differentiated but can still respond to the microbial stimulus lipopolysaccharide, which is important for selecting the appropriate injection route of human DC for tumor immunotherapy.